Molecular Templates is a clinical-stage biopharmaceutical company developing therapeutic compounds for cancer and other serious diseases.
Description
Molecular Templates is a clinical-stage biopharmaceutical company developing therapeutic compounds for cancer and other serious diseases. It primarily develops a pipeline of therapies through its proprietary biologic-engineered toxin body (ETB) drug platform with unique mechanisms of action which are highly differentiated from antibody-drug conjugates (ADCs).
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Austin, Texas, United States, North America
Founded on
January 1, 2000
Exited on
March 17, 2017
Went public on
March 17, 2017
Stock symbol
MTEM
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$34056 - 789030
Sign in for full access
Investors
Uh Ohhhh, Cannot Access, No Way, Uh Ohhhh, Noway Youcantaccess, Noaccess, Noaccess, No Way, Cannot Access, Noaccess, No Way, Noway Youcantaccess, Noway Youcantaccess, Noaccessforu